Considering that PTEN loss and PI3K pathway activation are known key drivers of carcinogenesis in endometrial cancer, we hypothesized that p110β could play a significant role particularly in PTEN-deficient tumors. This evidence concerns the gene PIK3CB and endometrial cancer.